Table 1.
Description of Study Population
| Intervention Period Group B |
||||||
|---|---|---|---|---|---|---|
| Total Group | Pre-impl. Group R | Paper impl. Group A | Computerized (B1) | Control (B2) | Postintervention Group C | |
| No. of patients | 484 | 225 | 116 | 66 | 54 | 23 |
| Mean age, yr (SD) | 67 ± 13 | 67 ± 12 | 68 ± 12 | 65 ± 13 | 65 ± 14 | 66 ± 13 |
| Gender male (%) | 298 (62) | 132 (59) | 71 (61) | 45 (68) | 36 (67) | 14 (60) |
| APACHE II (SD) | 20.3 ± 7.7 | 20 ± 7.8 | 20.7 ± 7.2 | 19.5 ± 7.4 | 21.6 ± 8.8 | 20.3 ± 6 |
| SAPS II (SD) | 41.7 ± 17 | 40.2 ± 16.1 | 43.9 ± 16.1 | 41.4 ± 18.9 | 43.3 ± 19.5 | 43 ± 18.6 |
| Preexisting DM, % | 25.2 | 18.0 | 19.8 | 42.4 | 38.8 | 39.0 |
| LOS (SD) | 4.4 ± 7 | 4.8 ± 8.5 | 4.6 ± 6.1 | 3.6 ± 5.1 | 3.7 ± 5.1 | 3.7 ± 3.9 |
| Surgical patients (%) | 321 (66.3) | 148 (65.7) | 72 (62.1) | 47 (71.2) | 39 (72.2) | 15 (65.2) |
Pre-impl. = preimplementation period; Paper impl. = period in which the guideline was only available in its paper form; APACHE II = average Acute Physiology, Age, and Chronic Health Evaluation II score; SAPS II = average Simplified Acute Physiology Score II; Preexisting DM = percentage of admitted patients with preexisting diabetes, irrespective of type; LOS = length of stay in Intensive Care Unit (days).